Chemical
CAS: 1365267-35-1
N,N′-bis[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]urea
Rivaroxaban EP Impurity D
Formula: C8322;8329;H8323;8322;N8326;O8329;
Specifications
Key details (from tblproducts)
| CAS | 1365267-35-1 |
| Category | Impurity |
| Molecular formula | C8322;8329;H8323;8322;N8326;O8329; |
| Molecular weight | 608.60 |
| IUPAC | N,N′-bis[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]urea |
Supplier listings below are pulled from tblproductsupplier + tblsuppliers.
Suppliers
Suppliers offering this product
| Supplier | Country | Stock | Action |
|---|---|---|---|
| Clearsynth | India | In Stock | View |
| TLC Pharmaceutical Standards Ltd | Canada | In Stock | View |
| Shanghai Forever Synthesis Co.,Ltd. | CHINA | In Stock | View |
| Toronto Research Chemicals | Canada | In Stock | View |
| Aozeal Certified Standards | United States | In Stock | View |
| GVP Bio Life Sciences | INDIA | In Stock | View |
| Hemarsh Technologies | INDIA | In Stock | View |
| Molcan Corporation | Canada | In Stock | View |
| Opulent Pharma | INDIA | In Stock | View |
| Pharmace Research Laboratory | INDIA | In Stock | View |
| Richchem | CHINA | In Stock | View |
| Shanghai ginposome | CHINA | In Stock | View |
| Shenzhen Readline Technology Co.,Ltd. | CHINA | — | View |
| Acanthus Research | Canada | In Stock | View |
| BNB LIFE SCIENCES | India | In Stock | View |
| chemicea pharmaceuticals pvt ltd | India | In Stock | View |
| Chemikos laboratories pvt ltd | India | In Stock | View |
| ChemNorm | CHINA | In Stock | View |
| Chengdu Sino-Strong Pharmaceutical Co.,Ltd. | China | — | View |
| Dalton Research Molecules | Canada | In Stock | View |
| GlycoMindsynth Pvt Ltd | India | In Stock | View |
| Goalsy Pharma Pvt Ltd. | India | In Stock | View |
| HengYao Shanghai biological technology | CHINA | In Stock | View |
| R K CHEMICALS | India | In Stock | View |
| RARE PHARMA LABS | India | In Stock | View |
| Shenzhen Excellent Biomedical Technology Co.,Ltd | In Stock | View |